MILLENNIUM MANAGEMENT LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 98 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 6.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,964,732
+968.3%
227,663
+1181.2%
0.00%
Q2 2023$183,909
+12031.2%
17,769
-87.3%
0.00%
-100.0%
Q1 2023$1,516
-80.0%
139,706
-79.3%
0.00%
-75.0%
Q4 2022$7,579
-99.9%
675,490
+3.8%
0.00%0.0%
Q3 2022$6,597,000
+3780.6%
650,558
+3553.8%
0.00%
Q1 2022$170,000
-34.6%
17,805
-24.2%
0.00%
Q4 2021$260,000
-97.0%
23,493
-98.0%
0.00%
-100.0%
Q3 2021$8,592,000
+293.0%
1,161,034
+671.2%
0.01%
+400.0%
Q2 2021$2,186,000
-9.9%
150,551
+26.7%
0.00%
-50.0%
Q1 2021$2,426,000
+462.9%
118,869
+390.1%
0.00%
Q4 2020$431,000
+75.2%
24,252
+45.5%
0.00%
Q3 2020$246,000
-90.5%
16,668
-83.4%
0.00%
-100.0%
Q4 2019$2,603,000
+590.5%
100,551
+504.9%
0.00%
+200.0%
Q1 2019$377,000
-91.2%
16,623
-87.4%
0.00%
-80.0%
Q3 2018$4,299,000
+339.1%
131,596
+204.9%
0.01%
+400.0%
Q2 2018$979,000
-39.9%
43,166
-35.7%
0.00%
-50.0%
Q1 2018$1,628,000
+288.5%
67,124
+346.4%
0.00%
+100.0%
Q4 2017$419,000
-32.3%
15,038
-22.6%
0.00%0.0%
Q4 2016$619,000
-40.0%
19,420
-69.2%
0.00%
-50.0%
Q4 2015$1,032,000
-23.8%
62,978
-48.9%
0.00%
-33.3%
Q3 2015$1,354,000
+129.5%
123,237
+171.9%
0.00%
+200.0%
Q2 2015$590,000
-32.6%
45,331
-10.2%
0.00%
-50.0%
Q1 2015$876,000
-60.4%
50,496
-66.0%
0.00%
-60.0%
Q4 2014$2,213,000
+833.8%
148,349
+1341.8%
0.01%
+400.0%
Q3 2014$237,00010,2890.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Woodford Investment Management Ltd 10,898,879$264,297,00023.51%
Foundation Asset Management, LP 399,537$9,689,0003.59%
Cormorant Asset Management, LP 1,300,000$31,525,0002.35%
Baupost Group 9,309,168$225,747,0002.18%
Old West Investment Management, LLC 109,320$2,651,0001.53%
SENZAR ASSET MANAGEMENT, LLC 187,856$4,555,0001.44%
Chescapmanager LLC 350,631$8,503,0001.27%
Virtus ETF Advisers LLC 32,989$800,0000.69%
Rock Springs Capital Management LP 652,600$15,826,0000.68%
NJ State Employees Deferred Compensation Plan 34,142$828,0000.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders